Metformin vs Nivolumab

## Metformin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Metformin** and **Nivolumab**.

## Mechanism of Action

**Metformin**: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Metformin — 4-9 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Metformin — C4H11N5; Nivolumab — N/A.

**Molecular Weight**: Metformin — 129.1640 g/mol; Nivolumab — N/A.

**Type**: Metformin — Small molecule; Nivolumab — Antibody.